Skip to main content

Table 1 Patient profiles

From: Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of patients with malignant gliomas

95-033

     

Case #

Age

Gender

Tumor

# of previous recurrence

Vaccine/Adverse events

1

63

Male

Lt. Temporal GBM

2

Yes/Grade 2 skin reaction

2

60

Male

Lt. Temporal AA

3

Yes/Grade 1 skin reaction

3

40

Male

Rt. Frontal GBM

3

No due to tumor progression

4

57

Male

Lt. Parieto/Occi GBM

1

No due to tumor progression

5

32

Female

Lt. Parieto/Occi GBM

1

No due to tumor progression

6

53

Female

Rt. Frontal GBM

2

No due to tumor progression

99-111

     

Case #

Age

Gender

Tumor

TTP (Months)

Vaccine/Adverse events

1

56

Male

Lt. Parietal GBM

4

Yes/Grade 1 headache

2

66

Male

Rt. Frontal GBM

N/A

No due to tumor progression

3

45

Male

Lt. Temporal GBM

10

Yes/None

4

53

Male

Lt. Occipital GBM

6

Yes/None

5

50

Male

Rt. Frontal GBM

6

Yes/None

6

61

Female

Rt. Temporal GBM

4

Yes/None

  1. TTP: Time To Progression